Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on December 11, 2012, regarding events occurring on December 10, 2012. The filing details the results of the Company's Annual Meeting of Stockholders held in San Diego, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
A total of 8,344,524 shares of common stock were represented at the meeting, constituting a quorum. The following matters were submitted to a vote:
- Proposal 1 (Election of Directors): All six nominees were elected unanimously with zero votes against. The directors elected are Gabriele M. Cerrone, Gary S. Jacob, Thomas H. Adams, John P. Brancaccio, Antonius Schuh, and Stanley Tennant. Each received 5,109,573 votes "For" and 1,967 votes "Abstain".
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2012. The vote count was 7,903,989 "For", 1,967 "Against", and 438,568 "Abstain".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of the Annual Meeting outcomes.
Important Facts for Investors to Verify
- Confirm the correct registrant name is Trovagene, Inc., as the input metadata referenced Cardiff Oncology, Inc.
- Verify the composition of the Board of Directors following the unanimous election of the six nominees.
- Note the ratification of BDO USA, LLP as the independent auditor for the 2012 fiscal year.
- Review the Definitive Proxy Statement filed on October 19, 2012, for detailed background on the proposals.